Validation of α-Synuclein in L1CAM-Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes.

Cheng JiangFranziska HopfnerDaniela BergMichele T HuAndrea PilottoBarbara BorroniJason J DavisGeorge K Tofaris

Published in: Movement disorders : official journal of the Movement Disorder Society (2021)

α-Synuclein and clusterin in L1CAM-immunocaptured serum exosomes is a validated blood test for the molecular stratification of neuronal α-synucleinopathy (ie, Lewy body pathology) versus phenotypically related neurodegenerative movement disorders. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keyphrases

mesenchymal stem cells
stem cells
parkinson disease
systematic review
brain injury
drug induced